Analysis of new biomarkers for cholangiocarcinoma

被引：5

作者：

Miwa, Masanao ^{[1
]}

You, Gyokukou ^{[1
]}

Tanaka, Hideaki ^{[1
]}

Taniguchi, Seigo ^{[1
]}

Fujii, Takahiro ^{[1
]}

Kamemura, Kazuo ^{[1
]}

Suzaki, Masafumi ^{[2
]}

Isono, Takahiro ^{[2
]}

Tooyama, Ikuo ^{[2
]}

Tanaka, Masakazu ^{[3
]}

Srivatanakul, Petcharin ^{[4
]}

Viwatthanasittiphong, Chutiwan ^{[5
]}

Sangrajrang, Suleeporn ^{[4
]}

Khuhaprema, Thiravud ^{[4
]}

机构：

[1] Nagahama Inst Biosci & Technol, Nagahama, Shiga 5260829, Japan

[2] Shiga Univ Med Sci, Otsu, Shiga 52021, Japan

[3] Kansai Med Univ, Hirakata, Osaka, Japan

[4] Natl Canc Inst, Bangkok, Thailand

[5] Ubon Canc Ctr, Ratchathani, Thailand

来源：

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES | 2014年 / 21卷 / 06期

关键词：

Biliary tract cancer; Cholangiocarcinoma; Opisthorchis viverrini; Tumor marker; WISTERIA-FLORIBUNDA AGGLUTININ; OPISTHORCHIS-VIVERRINI; THAILAND; CANCER; RISK; MARKER;

D O I：

10.1002/jhbp.69

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Cholangiocarcinoma is one of the most serious diseases in northeast Thailand, where its incidence is reported to be the highest in the world. We tried to develop a new method to detect cholangiocarcinoma in the early stages using serum proteins. We found that after fluorescent labeling of the sugar moiety of serum proteins, a new peak was identified, which might be a promising marker for cholangiocarcinoma.

引用

页码：397 / 398

页数：2

共 50 条

[1] A comparative proteomic analysis of bile for biomarkers of cholangiocarcinoma
Laohaviroj, Marut
Potriquet, Jeremy
Jia, Xinying
Suttiprapa, Sutas
Chamgramol, Yaovalux
Pairojkul, Chawalit
Sithithaworn, Paiboon
Mulvenna, Jason
Sripa, Banchob
TUMOR BIOLOGY, 2017, 39 (06)
[2] Proteomics Analysis and Evaluation of Biomarkers for Detection of Cholangiocarcinoma
Sriwanitchrak, Pramote
Viyanant, Vithoon
Chaijaroenkul, Wanna
Srivatanakul, Petcharin
Gram, Hans Rudi
Eursiddhichai, Veerachai
Na-Bangchang, Kesara
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2011, 12 (06) : 1503 - 1510
[3] Proteomic analysis to identify plasma orosomucoid 2 and kinesin 18A as potential biomarkers of cholangiocarcinoma
Rucksaken, Rucksak
Khoontawad, Jarinya
Roytrakul, Sittiruk
Pinlaor, Porntip
Hiraku, Yusuke
Wongkham, Chaisiri
Pairojkul, Chawalit
Boonmars, Thidarut
Pinlaor, Somchai
CANCER BIOMARKERS, 2012, 12 (02) : 81 - 95
[4] Transcriptomic analysis and identification of prognostic biomarkers in cholangiocarcinoma
Li, Hanyu
Long, Junyu
Xie, Fucun
Kang, Kai
Shi, Yue
Xu, Weiyu
Wu, Xiaoqian
Lin, Jianzhen
Xu, Haifeng
Du, Shunda
Xu, Yiyao
Zhao, Haitao
Zheng, Yongchang
Gu, Jin
ONCOLOGY REPORTS, 2019, 42 (05) : 1833 - 1842
[5] miRNA and lncRNA as biomarkers in cholangiocarcinoma(CCA)
Zheng, Bo
Jeong, Seogsong
Zhu, Yanjing
Chen, Lei
Xia, Qiang
ONCOTARGET, 2017, 8 (59) : 100819 - 100830
[6] Biomarkers and Management of Cholangiocarcinoma: Unveiling New Horizons for Precision Therapy
Nishida, Naoshi
CANCERS, 2025, 17 (07)
[7] Current omics-based biomarkers for cholangiocarcinoma
Intuyod, Kitti
Armartmuntree, Napat
Jusakul, Apinya
Sakonsinsiri, Chadamas
Thanan, Raynoo
Pinlaor, Somchai
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2019, 19 (11) : 997 - 1005
[8] Analysis of Different Ways of Drainage for Obstructive Jaundice Caused by Hilar Cholangiocarcinoma
Xu, Chuan
Lv, Peng-Hua
Huang, Xin-En
Wang, Shu-Xiang
Sun, Ling
Wang, Fu-An
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (14) : 5617 - 5620
[9] Serum and bile biomarkers for cholangiocarcinoma
Alvaro, Domenico
CURRENT OPINION IN GASTROENTEROLOGY, 2009, 25 (03) : 279 - 284
[10] Molecular diagnostics and biomarkers in cholangiocarcinoma
Brown, Zachary J.
Patwardhan, Satyajit
Bean, Joal
Pawlik, Timothy M.
SURGICAL ONCOLOGY-OXFORD, 2022, 44

← 1 2 3 4 5 →